Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns

Date:




The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Jason Aldean’s Favorite Hobby With His Son Might Surprise Fans

Jason Aldean just kicked off his Songs About Us...

Super Micro Computer Says Fourth-Quarter Margins Will Be Twice as High as Expected

The server company said it now expects gross margins...

Team Mexico relishes competing at NFR Open

Carlos "Chale" Ochoa has spent nearly a decade making...